Literature DB >> 29328362

MicroRNA-493-5p promotes apoptosis and suppresses proliferation and invasion in liver cancer cells by targeting VAMP2.

Guannan Wang1, Xiaosan Fang2, Meng Han2, Xiaoming Wang2, Qiang Huang1.   

Abstract

The aim of the present study was to explore the role of miR‑493-5p in liver cancer tissues and cell lines, and its effect on cell behavioral characteristics. The expression of miR-493-5p was detected by reverse transcription-quantitative polymerase chain reaction (RT-qPCR) in liver cancer tissues and cell lines (hepatic cell line HL-7702 and the liver cancer cell lines HCCC-9810, HuH-7 and HepG2). In addition, the mechanism by which miR-493-5p mediates its effects was analyzed via the transfection of miR-493-5p mimic and negative control miRNA into HepG2 cells. The viability, proliferation, apoptosis and invasion of the cells were analyzed using MTT assay, flow cytometry and Transwell chamber experiments. Furthermore, the effect of miR-493-5p on the expression of vesicle associated membrane protein 2 (VAMP2) was assayed using a dual-luciferase reporter system, and VAMP2 protein levels were determined by western blot analysis. In addition, following the cotransfection of HepG2 cells with pcDNA3.1‑VAMP2 plasmid and miR‑493-5p mimic, the role of miR-493-5p as a regulator of VAMP2 was evaluated using MTT assay, flow cytometry and Transwell chamber experiments. RT-qPCR analysis indicated that the expression of miR-493-5p in liver cancer tissues and cell lines was decreased significantly compared with that in adjacent normal liver tissues and normal liver cell lines, respectively. Compared with the control group, the cells transfected with miR-493-5p mimic (the miR-493-5p overexpression group) exhibited reduced cell viability, a reduced percentage of cells in the S phase and an increased percentage of apoptotic cells. In addition, fewer cells passed through the Transwell membrane in the miR-493-5p overexpression group compared with the control group. In the dual-luciferase reporter assay, luciferase activity in the miR‑493-5p overexpression group was attenuated compared with that in the control group. In addition, western blot analysis indicated that the VAMP2 protein levels in the miR‑493-5p overexpression group were lower than those in the control group. Furthermore, in cells overexpressing miR-493-5p and VAMP2 simultaneously, the biological behavior of the cells, including cell viability, cell cycle and cell invasiveness, was significantly rescued compared with that of the control group transfected with miR‑493-5p alone. In conclusion, miR-493-5p is indicated to be a tumor suppressor gene, and is downregulated in human liver cancer. miR-493-5p overexpression promotes cell apoptosis and inhibits the proliferation and migration of liver cancer cells by negatively regulating the expression of VAMP. These observations suggest the potential of treating liver cancer by the overexpression of microRNA-493-5p.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29328362     DOI: 10.3892/ijmm.2018.3358

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  17 in total

1.  miR-505 inhibits proliferation of osteosarcoma via HMGB1.

Authors:  Guangzhang Li; Fajing Liu; Jun Miao; Yongcheng Hu
Journal:  FEBS Open Bio       Date:  2020-05-31       Impact factor: 2.693

2.  Efficacy of abiraterone combined with flutamide on prostate cancer patients and its effect on serum miR-493-5p and miR-195-5p.

Authors:  Chunyan Yang; Yanling Dai; Shuhua Pang; Xiaomin Guo
Journal:  Oncol Lett       Date:  2020-06-09       Impact factor: 2.967

3.  Upregulation of microRNA 344a-3p is involved in curcumin induced apoptosis in RT4 schwannoma cells.

Authors:  Eun Jung Sohn; Kyoung-Mi Bak; Yun-Kyeong Nam; Hwan Tae Park
Journal:  Cancer Cell Int       Date:  2018-12-04       Impact factor: 5.722

4.  miR‑3666 suppresses cellular proliferation and invasion in colorectal cancer by targeting SATB2.

Authors:  Daqing Yang; Rizeng Li; Jianfu Xia; Wencai Li; Hong Zhou
Journal:  Mol Med Rep       Date:  2018-10-09       Impact factor: 2.952

5.  MEG3-derived miR-493-5p overcomes the oncogenic feature of IGF2-miR-483 loss of imprinting in hepatic cancer cells.

Authors:  Luc Gailhouste; Lee Chuen Liew; Ken Yasukawa; Izuho Hatada; Yasuhito Tanaka; Takashi Kato; Hitoshi Nakagama; Takahiro Ochiya
Journal:  Cell Death Dis       Date:  2019-07-18       Impact factor: 8.469

6.  Human CAP cells represent a novel source for functional, miRNA-loaded exosome production.

Authors:  Nikolas Zeh; Helga Schneider; Sven Mathias; Nadja Raab; Michael Kleemann; Sabine Schmidt-Hertel; Benjamin Weis; Silke Wissing; Nikola Strempel; René Handrick; Kerstin Otte
Journal:  PLoS One       Date:  2019-08-28       Impact factor: 3.240

7.  MicroRNA-493-5p-mediated repression of the MYCN oncogene inhibits hepatic cancer cell growth and invasion.

Authors:  Ken Yasukawa; Lee Chuen Liew; Keitaro Hagiwara; Ai Hironaka-Mitsuhashi; Xian-Yang Qin; Yutaka Furutani; Yasuhito Tanaka; Hitoshi Nakagama; Soichi Kojima; Takashi Kato; Takahiro Ochiya; Luc Gailhouste
Journal:  Cancer Sci       Date:  2020-01-25       Impact factor: 6.716

8.  Association between SNAP25 and human glioblastoma multiform: a comprehensive bioinformatic analysis.

Authors:  Cheng Yu; Jianxing Yin; Xiefeng Wang; Lijiu Chen; Yutian Wei; Chenfei Lu; Yongping You
Journal:  Biosci Rep       Date:  2020-06-26       Impact factor: 3.840

9.  Creation of a Prognostic Risk Prediction Model for Lung Adenocarcinoma Based on Gene Expression, Methylation, and Clinical Characteristics.

Authors:  Honggang Ke; Yunyu Wu; Runjie Wang; Xiaohong Wu
Journal:  Med Sci Monit       Date:  2020-10-06

10.  Long noncoding RNA highly upregulated in liver cancer promotes the progression of hepatocellular carcinoma and attenuates the chemosensitivity of oxaliplatin by regulating miR-383-5p/vesicle-associated membrane protein-2 axis.

Authors:  Peng Li; Yuwei Li; Lieting Ma
Journal:  Pharmacol Res Perspect       Date:  2021-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.